Rolipram, a Phosphodiesterase 4 Inhibitor, Stimulates Osteoclast Formation by Inducing TRANCE Expression in Mouse Calvarial Cells |
Cho, Eun-Sook
(College of Pharmacy, Sookmyung Women's University)
Yu, Ja-Heon (College of Pharmacy, Sookmyung Women's University) Kim, Mi-Sun (College of Pharmacy, Sookmyung Women's University) Yim, Mi-Jung (College of Pharmacy, Sookmyung Women's University) |
1 | Conti, M. and Jin, S. L., The molecular biology of cyclic nucleotide phosphodiesterases. Prog. Nucleic. Acid Res. Mol. Biol., 63,1-38 (1999) DOI |
2 | Kondo, H., Guo, J., and Bringhurst, F. R., Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells. J. Bone Miner. Res., 17, 1667-1679 (2002) DOI ScienceOn |
3 | Tsutsumimoto, T., Wakabayashi, S., Kinoshita, T., Horiuchi, H., and Takaoka, K., A phosphodiesterase inhibitor, pentoxifylline, enhances the bone morphogenetic protein-4 (BMP-4)dependent differentiation of osteoprogenitor cells. Bone, 31, 396-401 (2002) DOI ScienceOn |
4 | Houslay, M. D., Sullivan, M., and Bolger, G. B., The multienzyme PDE4 cyclic adenosine monophosphate-specific phosphodiesterase family: intracellular targeting, regulation, and selective inhibition by compounds exerting anti-inflammatory and antidepressant actions. Adv. Pharmacol., 44, 225-342 (1998) DOI |
5 | Waki, Y., Horita, T., Miyamoto, K., Ohya, K., and Kasugai, S., Effects of XT-44, a phosphodiesterase 4 inhibitor, in osteoblastgenesis and osteoclastgenesis in culture and its therapeutic effects in rat osteopenia models. Jpn. J Pharmacol., 79, 477-483 (1999) DOI |
6 | Wong, B. R., Rho, J., Arron, J., Robinson, E., Orlinick, J., Chao, M., Kalachikov, S., Cayani, E., Bartlett 3rd, F. S., Frankel, W. N., Lee, S. Y., and Choi, Y., TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun Nterminal kinase in T cells. J. Biol. Chem., 272, 25190-25194 (1997) DOI ScienceOn |
7 | Houslay, M. D. and Adams, D. R., PDE4 cAMP phosphodie sterases: modular enzymes that orchestrate signalling crosstalk, desensitization and compartmentalization. Biochem. J, 370, 1-18 (2003) DOI ScienceOn |
8 | Takahashi, N., Udagawa, N., and Suda, T. A., New member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/ RANKL, regulates osteoclast differentiation and function. Biochem .Biophys. Res.Commun., 256, 449-455 (1999) DOI ScienceOn |
9 | Suda, T., Jimi, E., Nakamura, I., and Takahashi, N., Role of 1 alpha, 25-dihydroxyvitamin D3 in osteoclast differentiation and function. Methods Enzymol., 282, 223-235 (1997) DOI PUBMED |
10 | Kinoshita, T., Kobayashi, S., Ebara, S., Yoshimura, Y., Horiuchi, H., Tsutsumimoto, T., Wakabayashi, S., and Takaoka, K., Phosphodiesterase inhibitors, pentoxifylline and rolipram, increase bone mass mainly by promoting bone formation in normal mice. Bone, 27, 811-817 (2000) DOI ScienceOn |
11 | Takahashi, N., Akatsu, T., Udagawa, N., Sasaki, T., Yamaguchi, A., Moseley, J. M., Martin, T. J., and Suda, T., Osteoblastic cells are involved in osteoclast formation. Endocrinology, 123, 2600-2602 (1988) DOI ScienceOn |
12 | Miyamoto, K., Waki, Y., Horita, T., Kasugai, S., and Ohya, K., Reduction of bone loss by denbufylline, an inhibitor of phosphodiesterase 4. Biochem. Pharmacol., 54, 613-617 (1997) DOI PUBMED ScienceOn |
13 | Fu, Q., Jilka R. L., Manolagas, S. C., and O'Brien, C. A., Parathyroid hormone stimulates receptor activator of NF kappa B ligand and inhibits osteoprotegerin expression via protein kinase A activation of cAMP-response elementbinding protein. J. Biol. Chem., 277, 48868-48875 (2002) DOI ScienceOn |
14 | Suda, T., Takahashi, N., Udagawa, N., Jimi, E, Gillespie, M. T., and Martin, T. J., Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev., 20, 345-357 (1999) DOI ScienceOn |
15 | Tam, C. S., Heersche, J. N., Murray, T. M., and Parsons, J. A., Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: differential effects of intermittent and continuous administration. Endocrinology, 110, 506-512 (1982) DOI ScienceOn |
16 | Vaananen, H. K., Zhao, H., Mulari, M., and Halleen, J. M., The cell biology of osteoclast function. J. Cell Sci., 113, 377-381 (2000) PUBMED |
17 | Essayan, D. M., Cyclic nucleotide phosphodiesterases. J. Allergy CIin. lmmunol., 108, 671-680 (2001) DOI ScienceOn |
18 | Wakabayashi, S., Tsutsumimoto, T., Kawasaki, S., Kinoshita, T., Horiuchi, H., and Takaoka, K., Involvement of phosphodiesterase isozymes in osteoblastic differentiation. J Bone Miner. Res., 17, 249-56 (2002) DOI ScienceOn |